US2017021064A1PendingUtilityA1
Bioerodable metallic stent with biodegradable polymer coating
Assignee: ABBOTT CARDIOVASCULAR SYSTEMS INCPriority: Apr 15, 1997Filed: Oct 6, 2016Published: Jan 26, 2017
Est. expiryApr 15, 2017(expired)· nominal 20-yr term from priority
A61F 2250/0067A61L 2300/606A61L 2300/604A61F 2210/0004A61L 31/028A61F 2002/91566A61F 2210/0076A61L 31/16A61L 31/10A61F 2/915A61L 31/148A61F 2002/91533A61F 2002/91583A61F 2/92A61F 2/82A61L 2300/45A61L 2300/416A61L 31/022A61L 31/146A61F 2250/003A61L 2400/12A61F 2/91A61F 2/0077Y10T29/49982
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A device and a method of manufacturing an implantable medical device, such as a stent, are described herein. The device includes a metallic region composed of a bioerodable metal and a polymer region composed of a biodegradable polymer contacting the metallic region. The metallic region may erode at a different rate when exposed to bodily fluids than the polymer region when exposed to bodily fluids. In certain embodiments, the polymer region is an outer layer and the metallic region is an inner layer of the device.
Claims
exact text as granted — not AI-modified1 . A stent comprising:
struts made of a metal comprising magnesium; and a coating on the struts, wherein the coating comprises a biodegradable polymer and a drug, wherein the biodegradable polymer is selected from the group consisting of poly(L-lactic acid) and poly(D,L-lactic acid), and wherein the struts have surfaces and the coating completely covers the surfaces of the struts.
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . A stent comprising a scaffolding including a pattern of interconnecting struts, wherein a cross section of a strut of the struts includes a core and a coating around the core, wherein the core is made of a bioerodible metal and the coating comprises a biodegradable polymer and a drug, wherein the biodegradable polymer is selected from the group consisting of poly(L-lactic acid), poly(D,L-lactic acid), and poly(lactide-co-glycolide).
7 . The stent of claim 6 , wherein the bioerodible metal is an alloy and comprises magnesium.
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . The stent of claim 6 , wherein upon implantation of the stent in a vessel, the core is configured to erode when erosion of the coating exposes a portion of the core to bodily fluids.
12 . The stent of claim 6 , wherein upon implantation of the stent in a vessel, the coating inhibits or prevents direct contact or exposure of the core to a vascular environment.
13 - 18 . (canceled)
19 . The stent of claim 1 , wherein the metal is an alloy.Join the waitlist — get patent alerts
Track US2017021064A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.